TXMD stock forecast
Our latest prediction for TherapeuticsMD, Inc.'s stock price was made on the Oct. 25, 2019 when the stock price was at 2.84$.
In the short term (2weeks), TXMD's stock price should outperform the market by 6.56%. During that period the price should oscillate between -9.28% and +19.44%.
In the medium term (3months), TXMD's stock price should outperform the market by 4.10%. During that period the price should oscillate between -21.79% and +43.54%.Get email alerts
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
At the moment the company generates 19M USD in revenues.
On its last earning announcement, the company reported a loss of -0.71$ per share.
The book value per share is 0.03$
Three months stock forecastOct. 25, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|